Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABAA receptor in mice

British Journal of Pharmacology

Volumn 167, Issue 3, 2012, Pages 587-598

  Qu, Wei Min ^a   Yue, Xiao Fang ^a   Sun, Yu ^a   Fan, Kun ^a,b   Chen, Chang Rui ^a   Hou, Yi Ping ^b   Urade, Yoshihiro ^c   Huang, Zhi Li ^a  

^a FUDAN UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

c Fos; electrophysiology; honokiol; receptor; rodents; sleep

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE; DIAZEPAM; FLUMAZENIL; HONOKIOL; PROTEIN C FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG STRUCTURE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NERVE CELL STIMULATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; NONREM SLEEP; PATCH CLAMP; POLYSOMNOGRAPHY; PREOPTIC AREA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REM SLEEP; SLEEP TIME; SLEEP WAKING CYCLE; SOMNOLENCE; WHOLE CELL;

ANIMALS; BIPHENYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FLUMAZENIL; GABA MODULATORS; GENE EXPRESSION; INJECTIONS, INTRAPERITONEAL; LIGNANS; MALE; MICE; MICE, INBRED C57BL; PATCH-CLAMP TECHNIQUES; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, GABA-A; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP, REM; TIME FACTORS;

EID: 84865227716     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02010.x     Document Type: Article

References (44)

1. Aeschbach D, Dijk DJ, Trachsel L, Brunner DP, Borbely AA, (1994). Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: effect of midazolam and zopiclone. Neuropsychopharmacology 11: 237-244.
2. Alexander SP, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164: S1-324.
3. Aragona M, (2000). Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report. Clin Neuropharmacol 23: 281-283.
4. Atack JR, Smith AJ, Emms F, McKernan RM, (1999). Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors. Neuropsychopharmacology 20: 255-262.
5. Breslau N, Roth T, Rosenthal L, Andreski P, (1996). Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 39: 411-418.
6. Buckner JD, Bernert RA, Cromer KR, Joiner TE, Schmidt NB, (2008). Social anxiety and insomnia: the mediating role of depressive symptoms. Depress Anxiety 25: 124-130.
7. Chen C, Tan R, Qu W, Wu Z, Wang Y, Urade Y, et al,. (2011). Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts anti-epileptic effects via GABA-benzodiazepine receptor complex in mice. Br J Pharmacol 164: 1534-1546.
8. Chu QP, Wang LE, Cui XY, Fu HZ, Lin ZB, Lin SQ, et al,. (2007). Extract of Ganoderma lucidum potentiates pentobarbital-induced sleep via a GABAergic mechanism. Pharmacol Biochem Behav 86: 693-698.
9. Ding DZ, (1992). Application of Banxia houpu decoction in psychiatric disorder. Shaanxi J Tradit Chin Med 13: 412-413.
10. Feinberg I, Maloney T, Campbell IG, (2000). Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications. J Psychiatr Res 34: 423-438.
11. Franklin KBJ, Paxinos G, (1997). The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, CA.
12. Gallopin T, Fort P, Eggermann E, Cauli B, Luppi PH, Rossier J, et al,. (2000). Identification of sleep-promoting neurons in vitro. Nature 404: 992-995.
13. Gong H, Szymusiak R, King J, Steininger T, McGinty D, (2000). Sleep-related c-Fos protein expression in the preoptic hypothalamus: effects of ambient warming. Am J Physiol Regul Integr Comp Physiol 279: R2079-R2088.
14. Huang ZL, Mochizuki T, Qu WM, Hong ZY, Watanabe T, Urade Y, et al,. (2006). Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci U S A 103: 4687-4692.
15. Kopp C, Rudolph U, Keist R, Tobler I, (2003). Diazepam-induced changes on sleep and the EEG spectrum in mice: role of the alpha3-GABA(A) receptor subtype. Eur J Neurosci 17: 2226-2230.
16. Kopp C, Rudolph U, Low K, Tobler I, (2004). Modulation of rhythmic brain activity by diazepam: GABA(A) receptor subtype and state specificity. Proc Natl Acad Sci U S A 101: 3674-3679.
17. Kuribara H, Stavinoha WB, Maruyama Y, (1998). Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J Pharm Pharmacol 50: 819-826.
18. Kuribara H, Kishi E, Kimura M, Weintraub ST, Maruyama Y, (2000). Comparative assessment of the anxiolytic-like activities of honokiol and derivatives. Pharmacol Biochem Behav 67: 597-601.
19. Landolt HP, Finelli LA, Roth C, Buck A, Achermann P, Borbely AA, (2000). Zolpidem and sleep deprivation: different effect on EEG power spectra. J Sleep Res 9: 175-183.
20. Li JM, Kong LD, (2001). Advances in the study on depressive and anxiety disorders treated with traditional Chinese medicine and herbal drugs. Zhongguo Zhong Yao Za Zhi 26: 805-807.
21. van Lier H, Drinkenburg WH, van Eeten YJ, Coenen AM, (2004). Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats. Neuropharmacology 47: 163-174.
22. Liu YW, Li J, Ye JH, (2010). Histamine regulates activities of neurons in the ventrolateral preoptic nucleus. J Physiol 588: 4103-4116.
23. Lu J, Greco MA, Shiromani P, Saper CB, (2000). Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 20: 3830-3842.
24. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
25. Oishi Y, Huang ZL, Fredholm BB, Urade Y, Hayaishi O, (2008). Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc Natl Acad Sci U S A 105: 19992-19997.
26. Paxinos G, Watson C, (1997). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego, CA.
27. Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ, (1997). Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 42: 209-212.
28. Qiu MH, Zhang R, Sun FY, (2003). Enhancement of ischemia-induced tyrosine phosphorylation of Kv1.2 by vascular endothelial growth factor via activation of phosphatidylinositol 3-kinase. J Neurochem 87: 1509-1517.
29. Qiu MH, Qu WM, Xu XH, Yan MM, Urade Y, Huang ZL, (2009). D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice. Pharmacol Biochem Behav 94: 16-23.
30. Qu WM, Huang ZL, Xu XH, Aritake K, Eguchi N, Nambu F, et al,. (2006). Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. Proc Natl Acad Sci U S A 103: 17949-17954.
31. Qu WM, Huang ZL, Xu XH, Matsumoto N, Urade Y, (2008). Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. J Neurosci 28: 8462-8469.
32. Qu WM, Xu XH, Yan MM, Wang YQ, Urade Y, Huang ZL, (2010). Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J Neurosci 30: 4382-4389.
33. Sherin JE, Shiromani PJ, McCarley RW, Saper CB, (1996). Activation of ventrolateral preoptic neurons during sleep. Science 271: 216-219.
34. Sherin JE, Elmquist JK, Torrealba F, Saper CB, (1998). Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 18: 4705-4721.
35. Stewart R, Besset A, Bebbington P, Brugha T, Lindesay J, Jenkins R, et al,. (2006). Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep 29: 1391-1397.
36. Szymusiak R, Alam N, Steininger TL, McGinty D, (1998). Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 803: 178-188.
37. Taferner B, Schuehly W, Huefner A, Baburin I, Wiesner K, Ecker GF, et al,. (2011). Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship. J Med Chem 54: 5349-5361.
38. Teng CM, Chen CC, Ko FN, Lee LG, Huang TF, Chen YP, et al,. (1988). Two antiplatelet agents from Magnolia officinalis. Thromb Res 50: 757-765.
39. Tobler I, Kopp C, Deboer T, Rudolph U, (2001). Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype. Proc Natl Acad Sci U S A 98: 6464-6469.
40. Tsuno N, Besset A, Ritchie K, (2005). Sleep and depression. J Clin Psychiatry 66: 1254-1269.
41. Vgontzas AN, Kales A, Bixler EO, (1995). Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics. Pharmacology 51: 205-223.
42. Winokur A, Gary KA, Rodner S, Rae-Red C, Fernando AT, Szuba MP, (2001). Depression, sleep physiology, and antidepressant drugs. Depress Anxiety 14: 19-28.
43. Xu Q, Yi LT, Pan Y, Wang X, Li YC, Li JM, et al,. (2008). Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry 32: 715-725.
44. Yan MM, Xu XH, Huang ZL, Yao MH, Urade Y, Qu WM, (2011). Selection of optimal epoch duration in assessment of rodent sleep-wake profiles. Sleep Biol Rhythms 9: 46-55.